92 related articles for article (PubMed ID: 8758481)
1. [Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results].
Blancard A; Monges P; Lacarelle B; Denis JP; Bongrand MC; Ragon CH; Gouin F
Pathol Biol (Paris); 1996 May; 44(5):384-8. PubMed ID: 8758481
[TBL] [Abstract][Full Text] [Related]
2. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
[TBL] [Abstract][Full Text] [Related]
3. Amphotericin B infused in 20% lipid emulsion.
Ryan KA
J Intraven Nurs; 1996; 19(3):123-5. PubMed ID: 8788829
[TBL] [Abstract][Full Text] [Related]
4. Amphotericin B formulated in a lipid emulsion.
Cleary JD
Ann Pharmacother; 1996 Apr; 30(4):409-12. PubMed ID: 8729899
[No Abstract] [Full Text] [Related]
5. Amphotericin B lipid preparations: what are the differences?
Adler-Moore JP; Proffitt RT
Clin Microbiol Infect; 2008 May; 14 Suppl 4():25-36. PubMed ID: 18430127
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
Morand K; Bartoletti AC; Bochot A; Barratt G; Brandely ML; Chast F
Int J Pharm; 2007 Nov; 344(1-2):150-3. PubMed ID: 17669608
[TBL] [Abstract][Full Text] [Related]
7. Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions.
Schmidt S; Müller RH
Int J Pharm; 2003 Mar; 254(1):3-5. PubMed ID: 12615399
[TBL] [Abstract][Full Text] [Related]
8. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.
Chavanet PY; Garry I; Charlier N; Caillot D; Kisterman JP; D'Athis M; Portier H
BMJ; 1992 Oct; 305(6859):921-5. PubMed ID: 1458072
[TBL] [Abstract][Full Text] [Related]
9. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
Pahissa A
Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
[No Abstract] [Full Text] [Related]
10. Stability of amphotericin B 0.05 and 0.5 mg/mL in 20% fat emulsion.
Owens D; Fleming RA; Restino MS; Cruz JM; Hurd DD
Am J Health Syst Pharm; 1997 Mar; 54(6):683-6. PubMed ID: 9075499
[No Abstract] [Full Text] [Related]
11. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
[TBL] [Abstract][Full Text] [Related]
12. Comment: compatibility of amphotericin B with lipid emulsions.
Montoro JB; López RM; Pou L
Ann Pharmacother; 1996 Dec; 30(12):1501. PubMed ID: 8968472
[No Abstract] [Full Text] [Related]
13. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
14. Comments concerning 'The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis'.
Washington C; Davis SS
Biopharm Drug Dispos; 1995 Aug; 16(6):529-31. PubMed ID: 7579034
[No Abstract] [Full Text] [Related]
15. Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.
Lopez RM; Ayestaran A; Pou L; Montoro JB; Hernandez M; Caragol I
Am J Health Syst Pharm; 1996 Nov; 53(22):2724-7. PubMed ID: 8931814
[TBL] [Abstract][Full Text] [Related]
16. [Parenteral nutrition: stability of lipid emulsions in different preparations].
Klaassen JA; Maiz A; Toro M; Acosta AM
Rev Med Chil; 1989 Nov; 117(11):1227-31. PubMed ID: 2519796
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B intralipid formulation: stability and particle size.
Ranchère JY; Latour JF; Fuhrmann C; Lagallarde C; Loreuil F
J Antimicrob Chemother; 1996 Jun; 37(6):1165-9. PubMed ID: 8836819
[TBL] [Abstract][Full Text] [Related]
18. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.
Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ
Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936
[TBL] [Abstract][Full Text] [Related]
19. Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections.
Sachs-Barrable K; Lee SD; Wasan EK; Thornton SJ; Wasan KM
Adv Drug Deliv Rev; 2008 Mar; 60(6):692-701. PubMed ID: 18053611
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS.
Manfredi R; Chiodo F
Pharmacotherapy; 1998; 18(5):1087-92. PubMed ID: 9758320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
